Navitor Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2014-06-26. The offering totals $23.5M, of which $13.5M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 34 people.
| Name | Role | Location |
|---|---|---|
| Rajeev Dadoo | Director | Philadelphia, PA |
| Kevin Bitterman | Director | Cambridge, MA |
| Jean-Francois Formela | Director | Cambridge, MA |
| Marian Nakada | Director | Ann Arbor, MI |
| Alan Crane | Director | Watertown, MA |
| David Madden | Director | MARIETTA, GA |
| Brian Gallagher | Director | New York, NY |
| Vinzenz Ploerer | Director | Brisbane, CA |
| Paul Friedman | Director | Rochester, MN |
| Georg Vlasuk | Director | Cambridge, MA |
| John Creecy | Director | San Antonio, TX |
| John Creecy | Executive Officer | San Antonio, TX |
| Richard Lundberg | Executive Officer | Cambridge, MA |
| Thomas Hughes | Executive Officer | Cambridge, MA |
| Alan P Crane | Director | Cambridge, MA |
| David P Madden | Director | Cambridge, MA |
| George P Vlasuk | Director | Cambridge, MA |
| George P Vlasuk | Executive Officer | Cambridge, MA |
| Rick P Lundberg | Executive Officer | Cambridge, MA |
| Kevin P Bitterman | Director | Cambridge, MA |
| Rajeev P Dadoo | Director | Cambridge, MA |
| Marian P Nakada, Ph.D. | Director | Cambridge, MA |
| Thomas P Hughes | Director | Cambridge, MA |
| Thomas P Hughes | Executive Officer | Cambridge, MA |
| Vinzenz P Ploerer | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2020-05-07 | D | $20.2M | $20.2M |
| 2019-01-02 | D | $11.3M | $11.3M |
| 2018-03-16 | D | $25.0M | $11.3M |
| 2015-12-22 | D | $33.3M | $12.0M |
| 2014-08-15 | D/A | $23.5M | $13.5M |
| 2013-10-02 | D | $12.2M | $10.2M |